Posts by Carey M. York-Best, MD
-
Ensuring OB/GYN Care is Gender-affirming Care
Massachusetts General Hospital physicians collaborate across disciplines to ensure that OB/GYN care for transgender patients is safe, inclusive, and affirming.
-
The Evolving Gynecologic Practice
In this video, Carey York-Best, MD, a gynecologic surgeon in the Department of Obstetrics and Gynecology at the Massachusetts General Hospital and division director, Benign Gynecology and Obstetrics, discusses their evolving gynecologic practice, adapting with clinical advances to offer patients the best care possible.
-
The Team-based Approach to Patient Care in Obstetrics & Gynecology
In this video, Carey York-Best, MD, a gynecologic surgeon in the Department of Obstetrics and Gynecology at the Massachusetts General Hospital and director of Benign Gynecology and Obstetrics, discusses the department's approach to team-based patient care.
Biography
Carey M. York-Best, MD, has been an attending physician at Massachusetts General Hospital since 1993. Currently, she is division director of Benign Gynecology and Obstetrics and the associate director of the third year clerkship director for Mass General at Harvard Medical School. Dr. York-Best provides specialized gynecologic care for abnormal bleeding, fibroids and endometriosis, including up to date medical and surgical technologies such as endometrial ablation, hysteroscopic surgery and laparoscopic and vaginal hysterectomy and myomectomy. Within a practice at Mass General West, Dr. York-Best cares for many women with advanced maternal age pregnancy, and she has expertise in minimally invasive gynecologic surgery, perimenopause and the gynecologic care of breast cancer patients. In addition to teaching, Dr. York-Best is interested in patient safety, teamwork training and simulation within the department.
Obstetrics & Gynecology Care at Mass General
The Mass General Department of Obstetrics & Gynecology offers the highest level of care to women. Our clinical and research team is a leader in advancing treatments for gynecologic cancers, menopause, high-risk obstetrics, infertility and urogynecology.